Literature DB >> 28943392

An integrative analysis of chemically-induced cirrhosis-associated hepatocarcinogenesis: Histological, biochemical and molecular features.

Guilherme Ribeiro Romualdo1, Tony Fernando Grassi2, Renata Leme Goto2, Mariana Baptista Tablas2, Lucas Tadeu Bidinotto3, Ana Angélica Henrique Fernandes4, Bruno Cogliati5, Luís Fernando Barbisan6.   

Abstract

This study aimed the integrative characterization of morphological, biochemical and molecular features of chemically-induced cirrhosis-associated hepatocarcinogenesis. Thus, male Wistar rats were submitted to a diethylnitrosamine (DEN)/thioacetamide (TAA)-induced model. Liver tissue was processed for global gene expression, histopathological and collagen evaluations; as well as immunohistochemical and oxidative stress analysis. Gene Ontology and functional analysis showed the upregulation of extracellular matrix deposition genes, such as collagen type I alpha 1 and 2 (Col1α1 and Col1α2) and tissue inhibitor of metalloproteinase 1 and 2 genes (Timp1 and Timp2). In agreement these findings, animals presented extensive liver cirrhosis with increased collagen deposition (Sirius red). Besides, the animals developed many glutathione S-transferase pi (GST-P)-positive preneoplastic lesions showing high cell proliferation (Ki-67), in keeping with the Gstp1 and Gstp2 increased gene expression. DEN/TAA-treated rats also showed the upregulation of tumorigenesis-related annexin A2 gene (Anxa2) and few neoplastic lesions (hepatocellular adenomas, carcinomas, and cholangiocarcinoma). In contrast, gene expression and activity of antioxidant enzymes were decreased (glutathione peroxidase, total glutathione-S-transferase, and catalase). The model featured remarkable similarities to human hepatocarcinogenesis. Our findings could bring up new molecular insights into cirrhosis-associated hepatocarcinogenesis, and provide a suitable animal model for the establishment of further diagnostic, preventive and therapeutic approaches.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Diethylnitrosamine; Hepatocarcinogenesis; Liver cirrhosis; Oligo microarray; Thioacetamide; Wistar rats

Mesh:

Substances:

Year:  2017        PMID: 28943392     DOI: 10.1016/j.toxlet.2017.09.015

Source DB:  PubMed          Journal:  Toxicol Lett        ISSN: 0378-4274            Impact factor:   4.372


  7 in total

Review 1.  Animal models of cholangiocarcinoma.

Authors:  Emilien Loeuillard; Samantha R Fischbach; Gregory J Gores; Sumera Rizvi
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2018-04-05       Impact factor: 5.187

2.  Fibrosis-associated hepatocarcinogenesis revisited: Establishing standard medium-term chemically-induced male and female models.

Authors:  Guilherme Ribeiro Romualdo; Gabriel Bacil Prata; Tereza Cristina da Silva; Ana Angélica Henrique Fernandes; Fernando Salvador Moreno; Bruno Cogliati; Luís Fernando Barbisan
Journal:  PLoS One       Date:  2018-09-13       Impact factor: 3.240

3.  Dunaliella salina microalgae oppose thioacetamide-induced hepatic fibrosis in rats.

Authors:  Farouk K El-Baz; Abeer A A Salama; Rehab A Hussein
Journal:  Toxicol Rep       Date:  2019-11-10

Review 4.  Selecting an Appropriate Experimental Animal Model for Cholangiocarcinoma Research.

Authors:  Man Li; Xueli Zhou; Wei Wang; Baoan Ji; Yu Shao; Qianyu Du; Jinghao Yao; Yan Yang
Journal:  J Clin Transl Hepatol       Date:  2022-02-11

5.  Resveratrol Reverses Thioacetamide-Induced Renal Assault with respect to Oxidative Stress, Renal Function, DNA Damage, and Cytokine Release in Wistar Rats.

Authors:  Seema Zargar; Mona Alonazi; Humaira Rizwana; Tanveer A Wani
Journal:  Oxid Med Cell Longev       Date:  2019-09-10       Impact factor: 6.543

6.  Calcitriol Prevents Neuroinflammation and Reduces Blood-Brain Barrier Disruption and Local Macrophage/Microglia Activation.

Authors:  Larissa Ragozo Cardoso de Oliveira; Luiza Ayumi Nishiyama Mimura; Thais Fernanda de Campos Fraga-Silva; Larissa Lumi Watanabe Ishikawa; Ana Angélica Henrique Fernandes; Sofia Fernanda Gonçalves Zorzella-Pezavento; Alexandrina Sartori
Journal:  Front Pharmacol       Date:  2020-03-12       Impact factor: 5.810

Review 7.  Therapy of Primary Liver Cancer.

Authors:  Mei Feng; Yisheng Pan; Ruirui Kong; Shaokun Shu
Journal:  Innovation (Camb)       Date:  2020-08-10
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.